2017 American association of clinical endocrinologists/endocrine society update on transgender medicine

Case discussions

Vin Tangpricha, Sabine E. Hannema, Michael S. Irwig, Walter Meyer, Joshua D. Safer, Wylie C. Hembree

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Increased numbers of transgender and gender-nonconforming people are presenting to physicians in the United States and abroad due to increased public recognition and acceptance and increased access to healthcare facilities. However, there are still gaps in medical knowledge among endocrinologists and other health care professionals. The purpose of these cases is to present several common clinical vignettes of transgender people presenting in an office setting that illustrate some of the key recommendations of the Endocrine Society's revised Endocrine Treatment of Gender Dysphoria/Gender Incongruent Persons guidelines, cosponsored by the American Association of Clinical Endocrinologists. Methods: Cases were developed based on these recently revised guidelines for gender-dysphoric and gender-nonconforming persons. Results: Six cases are presented that illustrate the diagnosis, treatment, and long-term management of trans-gender children and adults based on the revised guidelines for the endocrine care of gender-dysphoric and gender-nonconforming persons. Several key teaching points are presented from the presentation of these cases. Conclusion: Endocrinologists should be familiar with the revised guidelines for gender-dysphoric and gender-nonconforming persons. Important aspects of care are the diagnosis of gender dysphoria, the timing of treatment with gender-affirming hormones, and the long-term monitoring for potential adverse outcomes. Long-term health outcome studies are needed to further help guide care in this unique population. Abbreviations: BMI = body mass index GnRH = gonadotropin-releasing hormone HDL = high-density lipoprotein LDL = low-density lipoprotein.

Original languageEnglish (US)
Pages (from-to)1430-1436
Number of pages7
JournalEndocrine Practice
Volume23
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Transgender Persons
Medicine
Guidelines
Gonadotropin-Releasing Hormone
Delivery of Health Care
HDL Lipoproteins
LDL Lipoproteins
Teaching
Body Mass Index
Therapeutics
Outcome Assessment (Health Care)
Hormones
Physicians
Endocrinologists
Health
Population
Gender Dysphoria

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Tangpricha, V., Hannema, S. E., Irwig, M. S., Meyer, W., Safer, J. D., & Hembree, W. C. (2017). 2017 American association of clinical endocrinologists/endocrine society update on transgender medicine: Case discussions. Endocrine Practice, 23(12), 1430-1436. https://doi.org/10.4158/GL-2017-0115

2017 American association of clinical endocrinologists/endocrine society update on transgender medicine : Case discussions. / Tangpricha, Vin; Hannema, Sabine E.; Irwig, Michael S.; Meyer, Walter; Safer, Joshua D.; Hembree, Wylie C.

In: Endocrine Practice, Vol. 23, No. 12, 01.12.2017, p. 1430-1436.

Research output: Contribution to journalArticle

Tangpricha, V, Hannema, SE, Irwig, MS, Meyer, W, Safer, JD & Hembree, WC 2017, '2017 American association of clinical endocrinologists/endocrine society update on transgender medicine: Case discussions', Endocrine Practice, vol. 23, no. 12, pp. 1430-1436. https://doi.org/10.4158/GL-2017-0115
Tangpricha, Vin ; Hannema, Sabine E. ; Irwig, Michael S. ; Meyer, Walter ; Safer, Joshua D. ; Hembree, Wylie C. / 2017 American association of clinical endocrinologists/endocrine society update on transgender medicine : Case discussions. In: Endocrine Practice. 2017 ; Vol. 23, No. 12. pp. 1430-1436.
@article{18d8974cfe224591a6410936b154b0a4,
title = "2017 American association of clinical endocrinologists/endocrine society update on transgender medicine: Case discussions",
abstract = "Objective: Increased numbers of transgender and gender-nonconforming people are presenting to physicians in the United States and abroad due to increased public recognition and acceptance and increased access to healthcare facilities. However, there are still gaps in medical knowledge among endocrinologists and other health care professionals. The purpose of these cases is to present several common clinical vignettes of transgender people presenting in an office setting that illustrate some of the key recommendations of the Endocrine Society's revised Endocrine Treatment of Gender Dysphoria/Gender Incongruent Persons guidelines, cosponsored by the American Association of Clinical Endocrinologists. Methods: Cases were developed based on these recently revised guidelines for gender-dysphoric and gender-nonconforming persons. Results: Six cases are presented that illustrate the diagnosis, treatment, and long-term management of trans-gender children and adults based on the revised guidelines for the endocrine care of gender-dysphoric and gender-nonconforming persons. Several key teaching points are presented from the presentation of these cases. Conclusion: Endocrinologists should be familiar with the revised guidelines for gender-dysphoric and gender-nonconforming persons. Important aspects of care are the diagnosis of gender dysphoria, the timing of treatment with gender-affirming hormones, and the long-term monitoring for potential adverse outcomes. Long-term health outcome studies are needed to further help guide care in this unique population. Abbreviations: BMI = body mass index GnRH = gonadotropin-releasing hormone HDL = high-density lipoprotein LDL = low-density lipoprotein.",
author = "Vin Tangpricha and Hannema, {Sabine E.} and Irwig, {Michael S.} and Walter Meyer and Safer, {Joshua D.} and Hembree, {Wylie C.}",
year = "2017",
month = "12",
day = "1",
doi = "10.4158/GL-2017-0115",
language = "English (US)",
volume = "23",
pages = "1430--1436",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "12",

}

TY - JOUR

T1 - 2017 American association of clinical endocrinologists/endocrine society update on transgender medicine

T2 - Case discussions

AU - Tangpricha, Vin

AU - Hannema, Sabine E.

AU - Irwig, Michael S.

AU - Meyer, Walter

AU - Safer, Joshua D.

AU - Hembree, Wylie C.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Objective: Increased numbers of transgender and gender-nonconforming people are presenting to physicians in the United States and abroad due to increased public recognition and acceptance and increased access to healthcare facilities. However, there are still gaps in medical knowledge among endocrinologists and other health care professionals. The purpose of these cases is to present several common clinical vignettes of transgender people presenting in an office setting that illustrate some of the key recommendations of the Endocrine Society's revised Endocrine Treatment of Gender Dysphoria/Gender Incongruent Persons guidelines, cosponsored by the American Association of Clinical Endocrinologists. Methods: Cases were developed based on these recently revised guidelines for gender-dysphoric and gender-nonconforming persons. Results: Six cases are presented that illustrate the diagnosis, treatment, and long-term management of trans-gender children and adults based on the revised guidelines for the endocrine care of gender-dysphoric and gender-nonconforming persons. Several key teaching points are presented from the presentation of these cases. Conclusion: Endocrinologists should be familiar with the revised guidelines for gender-dysphoric and gender-nonconforming persons. Important aspects of care are the diagnosis of gender dysphoria, the timing of treatment with gender-affirming hormones, and the long-term monitoring for potential adverse outcomes. Long-term health outcome studies are needed to further help guide care in this unique population. Abbreviations: BMI = body mass index GnRH = gonadotropin-releasing hormone HDL = high-density lipoprotein LDL = low-density lipoprotein.

AB - Objective: Increased numbers of transgender and gender-nonconforming people are presenting to physicians in the United States and abroad due to increased public recognition and acceptance and increased access to healthcare facilities. However, there are still gaps in medical knowledge among endocrinologists and other health care professionals. The purpose of these cases is to present several common clinical vignettes of transgender people presenting in an office setting that illustrate some of the key recommendations of the Endocrine Society's revised Endocrine Treatment of Gender Dysphoria/Gender Incongruent Persons guidelines, cosponsored by the American Association of Clinical Endocrinologists. Methods: Cases were developed based on these recently revised guidelines for gender-dysphoric and gender-nonconforming persons. Results: Six cases are presented that illustrate the diagnosis, treatment, and long-term management of trans-gender children and adults based on the revised guidelines for the endocrine care of gender-dysphoric and gender-nonconforming persons. Several key teaching points are presented from the presentation of these cases. Conclusion: Endocrinologists should be familiar with the revised guidelines for gender-dysphoric and gender-nonconforming persons. Important aspects of care are the diagnosis of gender dysphoria, the timing of treatment with gender-affirming hormones, and the long-term monitoring for potential adverse outcomes. Long-term health outcome studies are needed to further help guide care in this unique population. Abbreviations: BMI = body mass index GnRH = gonadotropin-releasing hormone HDL = high-density lipoprotein LDL = low-density lipoprotein.

UR - http://www.scopus.com/inward/record.url?scp=85044140085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044140085&partnerID=8YFLogxK

U2 - 10.4158/GL-2017-0115

DO - 10.4158/GL-2017-0115

M3 - Article

VL - 23

SP - 1430

EP - 1436

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 12

ER -